Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients
Immunosuppressive drugs commonly used in the treatment of psoriatic arthritis make patients more susceptible to viral, bacterial, and fungal infections because of their mechanism of action. They not only increase the risk of new infections but also act altering the natural course of preexisting infe...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2013/410521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849304733263593472 |
|---|---|
| author | R. Laurenti F. Giovannangeli E. Gubinelli M. T. Viviano A. Errico L. Leoni E. Ballanti A. Migliore |
| author_facet | R. Laurenti F. Giovannangeli E. Gubinelli M. T. Viviano A. Errico L. Leoni E. Ballanti A. Migliore |
| author_sort | R. Laurenti |
| collection | DOAJ |
| description | Immunosuppressive drugs commonly used in the treatment of psoriatic arthritis make patients more susceptible to viral, bacterial, and fungal infections because of their mechanism of action. They not only increase the risk of new infections but also act altering the natural course of preexisting infections. While numerous data regarding the reactivation of tuberculosis infection are available in the literature, poor information about the risk of reactivation or exacerbation of hepatitis viruses B and C infections during treatment with biologics has been reported. Furthermore, reported series with biological therapy included short periods of followup, and therefore, they are not adequate to verify the risk of reactivation in the long-term treatment. Our study evaluated patients with a history of hepatitis B and psoriatic arthritis treated with adalimumab and monitored up to six years. During the observation period, treatment was effective and well tolerated in all patients, and liver function tests and viral load levels remained unchanged. |
| format | Article |
| id | doaj-art-3db1213e2d344414a3d8b9deb890fa6c |
| institution | Kabale University |
| issn | 1740-2522 1740-2530 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical and Developmental Immunology |
| spelling | doaj-art-3db1213e2d344414a3d8b9deb890fa6c2025-08-20T03:55:40ZengWileyClinical and Developmental Immunology1740-25221740-25302013-01-01201310.1155/2013/410521410521Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 PatientsR. Laurenti0F. Giovannangeli1E. Gubinelli2M. T. Viviano3A. Errico4L. Leoni5E. Ballanti6A. Migliore7Unità di Reumatologia, Istituto Dermopatico dell’Immacolata-IRCCS, Via Monti di Creta 104, 00165 Rome, ItalyUnità di Reumatologia, Ospedale S. Pietro Fatebenefratelli, Via Cassia 600, 00189 Rome, ItalyUnità di Dermatologia, Istituto Dermopatico dell’Immacolata-IRCCS, Via Monti di Creta 104, 00165 Rome, ItalyUnità di Dermatologia, Istituto Dermopatico dell’Immacolata-IRCCS, Via Monti di Creta 104, 00165 Rome, ItalyUnità di Gastroenterologia, Ospedale San Carlo, Via Aurelia 275, 00165 Rome, ItalyUnità di Dermatologia, Istituto Dermopatico dell’Immacolata-IRCCS, Via Monti di Creta 104, 00165 Rome, ItalyUnità di Reumatologia, Ospedale S. Pietro Fatebenefratelli, Via Cassia 600, 00189 Rome, ItalyUnità di Reumatologia, Ospedale S. Pietro Fatebenefratelli, Via Cassia 600, 00189 Rome, ItalyImmunosuppressive drugs commonly used in the treatment of psoriatic arthritis make patients more susceptible to viral, bacterial, and fungal infections because of their mechanism of action. They not only increase the risk of new infections but also act altering the natural course of preexisting infections. While numerous data regarding the reactivation of tuberculosis infection are available in the literature, poor information about the risk of reactivation or exacerbation of hepatitis viruses B and C infections during treatment with biologics has been reported. Furthermore, reported series with biological therapy included short periods of followup, and therefore, they are not adequate to verify the risk of reactivation in the long-term treatment. Our study evaluated patients with a history of hepatitis B and psoriatic arthritis treated with adalimumab and monitored up to six years. During the observation period, treatment was effective and well tolerated in all patients, and liver function tests and viral load levels remained unchanged.http://dx.doi.org/10.1155/2013/410521 |
| spellingShingle | R. Laurenti F. Giovannangeli E. Gubinelli M. T. Viviano A. Errico L. Leoni E. Ballanti A. Migliore Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients Clinical and Developmental Immunology |
| title | Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients |
| title_full | Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients |
| title_fullStr | Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients |
| title_full_unstemmed | Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients |
| title_short | Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients |
| title_sort | long term safety of anti tnf adalimumab in hbc antibody positive psoriatic arthritis patients a retrospective case series of 8 patients |
| url | http://dx.doi.org/10.1155/2013/410521 |
| work_keys_str_mv | AT rlaurenti longtermsafetyofantitnfadalimumabinhbcantibodypositivepsoriaticarthritispatientsaretrospectivecaseseriesof8patients AT fgiovannangeli longtermsafetyofantitnfadalimumabinhbcantibodypositivepsoriaticarthritispatientsaretrospectivecaseseriesof8patients AT egubinelli longtermsafetyofantitnfadalimumabinhbcantibodypositivepsoriaticarthritispatientsaretrospectivecaseseriesof8patients AT mtviviano longtermsafetyofantitnfadalimumabinhbcantibodypositivepsoriaticarthritispatientsaretrospectivecaseseriesof8patients AT aerrico longtermsafetyofantitnfadalimumabinhbcantibodypositivepsoriaticarthritispatientsaretrospectivecaseseriesof8patients AT lleoni longtermsafetyofantitnfadalimumabinhbcantibodypositivepsoriaticarthritispatientsaretrospectivecaseseriesof8patients AT eballanti longtermsafetyofantitnfadalimumabinhbcantibodypositivepsoriaticarthritispatientsaretrospectivecaseseriesof8patients AT amigliore longtermsafetyofantitnfadalimumabinhbcantibodypositivepsoriaticarthritispatientsaretrospectivecaseseriesof8patients |